Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2017

01-12-2017 | Original article

The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics

Authors: Susumu Ogawa, Junko Takiguchi, Manami Shimizu, Kazuhiro Nako, Masashi Okamura, Yoshitaka Kinouchi, Sadayoshi Ito

Published in: Clinical and Experimental Nephrology | Issue 6/2017

Login to get access

Abstract

Background/aims

In diabetic patients, reduced urinary pH (UpH) is a predictive factor for cardiorenal-vascular disorders. Synthesis of glutathione, an anti-oxidative stress substance, is induced to counteract renal oxidative stress. UpH declines as glutamate is consumed, as does the synthesis of ammonia from glutamate. Glutathione is synthesized from glutamate and cysteine; however, in diabetes, the relationship between lowered UpH and the roles of renal amino acids is unknown. We, therefore, examined the relationship between amino-acid kinetics, UpH, and renal function.

Methods

This cross-sectional study targeted 100 non-diabetic obese individuals (OG: obese group) and 100 diabetics (DG: diabetic group). We investigated their blood amino acids, urinary amino-acid excretion, the reabsorption rates of various amino acids, and their relationship with the UpH and estimated glomerular filtration rate (eGFR).

Results

The DG subjects showed higher blood cysteine concentration, urinary glutamate, and cysteine excretions than the OG subjects. Although the glutamate reabsorption rate declined in the DG subjects, that of cysteine increased due to the lowered eGFR. The DG subjects’ urinary cysteine excretion correlated positively with UpH, making this urinary cysteine excretion the sole independent risk factor for lower UpH.

Conclusion

In patients with diabetes, the reabsorbed amount of cysteine, not glutamate, regulates the amount of glutathione synthesis in the kidneys. The more an amount of cysteine reabsorption increases concurrently with a decline in eGFR, the more its urinary excretion decreases. Under these conditions, concurrently, the glutamate consumption then increases, resulting in decreased ammonia synthesis and UpH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wu Y, Zhang M, Liu R, Zhao C. Oxidative stress-activated NHE1 is involved in high glucose-induced apoptosis in renal tubular epithelial cells. Yonsei Med J. 2016;57:1252–9.CrossRefPubMedPubMedCentral Wu Y, Zhang M, Liu R, Zhao C. Oxidative stress-activated NHE1 is involved in high glucose-induced apoptosis in renal tubular epithelial cells. Yonsei Med J. 2016;57:1252–9.CrossRefPubMedPubMedCentral
2.
go back to reference Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E, Akiyama Y, Toyohara T, Suzuki T, Tanemoto M, Abe T, Sato H, Yamamoto M, Ito S. Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J Am Soc Nephrol. 2011;22:635–48.CrossRefPubMedPubMedCentral Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E, Akiyama Y, Toyohara T, Suzuki T, Tanemoto M, Abe T, Sato H, Yamamoto M, Ito S. Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J Am Soc Nephrol. 2011;22:635–48.CrossRefPubMedPubMedCentral
3.
go back to reference Sato E, Mori T, Satoh M, Fujiwara M, Nakamichi Y, Oba I, Ogawa S, Kinouchi Y, Sato H, Ito S, Hida W. Urinary angiotensinogen excretion is associated with blood pressure in obese young adults. Clin Exp Hypertens. 2016;38:203–8.CrossRefPubMed Sato E, Mori T, Satoh M, Fujiwara M, Nakamichi Y, Oba I, Ogawa S, Kinouchi Y, Sato H, Ito S, Hida W. Urinary angiotensinogen excretion is associated with blood pressure in obese young adults. Clin Exp Hypertens. 2016;38:203–8.CrossRefPubMed
4.
go back to reference Ogawa S, Takiguchi J, Nako K, Okamura M, Sakamoto T, Kabayama S, Mori T, Kinouchi Y, Ito S. Elucidation of the etiology and characteristics of pink urine in young healthy subjects. Clin Exp Nephrol. 2015;19:822–9.CrossRefPubMed Ogawa S, Takiguchi J, Nako K, Okamura M, Sakamoto T, Kabayama S, Mori T, Kinouchi Y, Ito S. Elucidation of the etiology and characteristics of pink urine in young healthy subjects. Clin Exp Nephrol. 2015;19:822–9.CrossRefPubMed
5.
go back to reference Ogawa S, Nako K, Okamura M, Ito S. Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes. BMJ Open Diabetes Res Care. 2015;3:e000097.CrossRefPubMedPubMedCentral Ogawa S, Nako K, Okamura M, Ito S. Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes. BMJ Open Diabetes Res Care. 2015;3:e000097.CrossRefPubMedPubMedCentral
6.
go back to reference Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension. 2006;47:699–705.CrossRefPubMed Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension. 2006;47:699–705.CrossRefPubMed
7.
go back to reference Ogawa S, Takiguchi J, Shimizu M, Nako K, Okamura M, Kinouchi Y, Ito S. The reduction in urinary glutamate excretion is responsible for lowering urinary pH in pink urine syndrome. Tohoku J Exp Med. 2016;239:103–10.CrossRefPubMed Ogawa S, Takiguchi J, Shimizu M, Nako K, Okamura M, Kinouchi Y, Ito S. The reduction in urinary glutamate excretion is responsible for lowering urinary pH in pink urine syndrome. Tohoku J Exp Med. 2016;239:103–10.CrossRefPubMed
8.
go back to reference Tada K, Hirono H, Arakawa T. Endogenous renal clearance rates of free amino acids in prolinuric and Hartnup patients. Tohoku J Exp Med. 1967;93:57–61.CrossRefPubMed Tada K, Hirono H, Arakawa T. Endogenous renal clearance rates of free amino acids in prolinuric and Hartnup patients. Tohoku J Exp Med. 1967;93:57–61.CrossRefPubMed
9.
go back to reference Hunter EA, Grimble RF. Dietary sulphur amino acid adequacy influences glutathione synthesis and glutathione-dependent enzymes during the inflammatory response to endotoxin and tumor necrosis factor-alpha in rats. Clin Sci (Lond). 1997;92:297–305.CrossRef Hunter EA, Grimble RF. Dietary sulphur amino acid adequacy influences glutathione synthesis and glutathione-dependent enzymes during the inflammatory response to endotoxin and tumor necrosis factor-alpha in rats. Clin Sci (Lond). 1997;92:297–305.CrossRef
10.
go back to reference Ferguson G, Bridge W. Glutamate cysteine ligase and the age-related decline in cellular glutathione: the therapeutic potential of γ-glutamylcysteine. Arch Biochem Biophys. 2016;593:12–23.CrossRefPubMed Ferguson G, Bridge W. Glutamate cysteine ligase and the age-related decline in cellular glutathione: the therapeutic potential of γ-glutamylcysteine. Arch Biochem Biophys. 2016;593:12–23.CrossRefPubMed
11.
go back to reference Chen Y, Dong H, Thompson DC, Shertzer HG, Nebert DW, Vasiliou V. Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol. 2013;60:38–44.CrossRefPubMedPubMedCentral Chen Y, Dong H, Thompson DC, Shertzer HG, Nebert DW, Vasiliou V. Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol. 2013;60:38–44.CrossRefPubMedPubMedCentral
12.
go back to reference Dalton TP, Chen Y, Schneider SN, Nebert DW, Shertzer HG. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med. 2004;37:1511–26.CrossRefPubMed Dalton TP, Chen Y, Schneider SN, Nebert DW, Shertzer HG. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med. 2004;37:1511–26.CrossRefPubMed
15.
go back to reference Pathirana C, Grimble RF. Taurine and serine supplementation modulates the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet. J Nutr. 1992;122:1369–75.PubMed Pathirana C, Grimble RF. Taurine and serine supplementation modulates the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet. J Nutr. 1992;122:1369–75.PubMed
16.
go back to reference Nakatsu D, Horiuchi Y, Kano F, Noguchi Y, Sugawara T, Takamoto I, Kubota N, Kadowaki T, Murata M. l-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2. Proc Natl Acad Sci USA. 2015;112:E1067–76.CrossRefPubMedPubMedCentral Nakatsu D, Horiuchi Y, Kano F, Noguchi Y, Sugawara T, Takamoto I, Kubota N, Kadowaki T, Murata M. l-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2. Proc Natl Acad Sci USA. 2015;112:E1067–76.CrossRefPubMedPubMedCentral
18.
go back to reference Dröge W. Oxidative aging and insulin receptor signaling. J Gerontol A Biol Sci Med Sci. 2005;60:1378–85.CrossRefPubMed Dröge W. Oxidative aging and insulin receptor signaling. J Gerontol A Biol Sci Med Sci. 2005;60:1378–85.CrossRefPubMed
19.
go back to reference Dröge W, Kinscherf R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid Redox Signal. 2008;10:661–78.CrossRefPubMed Dröge W, Kinscherf R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid Redox Signal. 2008;10:661–78.CrossRefPubMed
Metadata
Title
The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics
Authors
Susumu Ogawa
Junko Takiguchi
Manami Shimizu
Kazuhiro Nako
Masashi Okamura
Yoshitaka Kinouchi
Sadayoshi Ito
Publication date
01-12-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1401-1

Other articles of this Issue 6/2017

Clinical and Experimental Nephrology 6/2017 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.